Intravitreal corticosteroids as an adjunct in the treatment of bacterial and fungal endophthalmitis. A review

Retina. 1992;12(4):336-40. doi: 10.1097/00006982-199212040-00007.

Abstract

The use of intravitreal corticosteroids in the management of endophthalmitis remains controversial. Several clinical and experimental reports are reviewed that suggest that intravitreal corticosteroid therapy, when used in conjunction with antibiotics with and without vitrectomy, reduces the intraocular inflammatory process and secondary complications associated with microbial endophthalmitis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Chemotherapy, Adjuvant
  • Endophthalmitis / drug therapy*
  • Endophthalmitis / microbiology
  • Eye Infections, Bacterial / drug therapy*
  • Eye Infections, Fungal / drug therapy*
  • Glucocorticoids / therapeutic use*
  • Humans
  • Injections
  • Vitreous Body

Substances

  • Anti-Bacterial Agents
  • Glucocorticoids